Abstract
Skin marks are widely used in external radiation therapy to ensure the accuracy of the irradiation position. However, conventional skin markers contain harmful substance, so we developed an alternative skin marker. The purpose of this study was to investigate the feasibility of using a novel water-based pigment marker comprising safe materials commonly used in cosmetics for clinical radiation therapy. We investigated various properties of the marker, namely marker longevity, color variety, line visibility, ink bleeding, and line durability, and improved the marker in response to the feel when drawing or being drawn on. The durability of the ink was evaluated by simultaneously applying the new marker and oil-based pen and comparing the period until the marks faded and became invisible. In clinical trial, we applied marks on the skin of 56 patients over three months to observe symptoms and visible changes in the skin. There were no complications of discomfort or pain, owing to the improvements in the marker tip. The marks drawn on the arms of volunteers with the new marker and the oil-based pen remained visible for a mean of 7.2 days and 3.6 days, respectively (P value < 0.001). The percentages of participants with no symptoms and no visible changes were 100%, respectively. We developed an alternative skin marker that complies with current regulatory standards by excluding crystal violet. The newly developed marker has features suitable for clinical use, such as resistance to smudging and water, marker tip shape and texture, and color variations.
Similar content being viewed by others
References
Jones D. ICRU report 50-prescribing, recording and reporting photon beam therapy. Med Phys. 1994;21:833–4.
Morgan-Fletcher SL. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50), ICRU report 62. Br J Radiol. 2001;74:294.
American Association of Physicists in Medicine (1984) AAPM Report 13: physical aspects of quality assurance in radiation therapy. AAPM Rep
Yabutani T, Suzuki S, Arakawa S, Yokoyama K, Kinomura Y, Katada K. Verification of the portal skin mark for radiotherapy. Nihon Hoshasen Gijutsu Gakkai zasshi. 2003;59:1295–302.
Wurstbauer K, Sedlmayer F, Kogelnik HD. Skin markings in external radiotherapy by temporary tattooing with henna: improvement of accuracy and increased patient comfort. Int J Radiat Oncol Biol Phys. 2001;50:179–81.
Rathod S, Munshi A, Agarwal J. Skin markings methods and guidelines: a reality in image guidance radiotherapy era. South Asian J Cancer. 2012;1:27–9.
Health Canada. Important Safety Information. https://recalls-rappels.canada.ca/en/alert-recall/health-canada-warns-canadians-potential-cancer-risk-associated-gentian-violet (12 Jun 2019, date last accessed)
Goto M, Oshiro Y, Tamaki Y, Ishida T, Kato Y, Shinoda K, Sakurai H. A novel method for skin marking in radiotherapy: first clinical use of temporary organic tattoo seal. J Radiat Res. 2022;63:314–8.
Pharmaceutical Safety and Environmental Health Bureau of Health, Labour and Welfare. Conventions on Methylrozaniline Chloride. https://www.pmda.go.jp/files/000244221.pdf (28 Dec 2021, date last accessed)
Asada H, Takahashi Y, Ono Y, Kishi N, Matsuo Y, Mizowaki T, Nakayama T. Emotional experiences of skin markings among patients undergoing radiotherapy and related factors: a questionnaire-based cross-sectional study. Patient Prefer Adherence. 2022;16:1359–69.
Pharmaceutical Safety and Environmental Health Bureau of Health, Labour and Welfare. Standards for Quasi-drug Ingredients. https://www.mhlw.go.jp/content/000839905.pdf (25 Mar 2021, date last accessed).
Bircher AJ, Sigg R, Scherer Hofmeier K, Schlegel U, Hauri U. Allergic contact dermatitis caused by a new temporary blue–black tattoo dye—sensitization to genipin from jagua (Genipa americana L.) fruit extract. Contact Dermatitis. 2017;77:374–8.
Townend C, Landeg S, Thorne R, Kirby AM, McNair HA. A review of permanent marking for radiotherapy in the UK. Radiography (Lond). 2020;26:9–14.
Haraldsson A, Ceberg S, Ceberg C, Bäck S, Engelholm S, Engström PE. Surface-guided tomotherapy improves positioning and reduces treatment time: a retrospective analysis of 16835 treatment fractions. J Appl Clin Med Phys. 2020;21:139–48.
Kügele M, Mannerberg A, Nørring Bekke S, Alkner S, Berg L, Mahmood F, Thornberg C, Edvardsson A, Bäck SÅJ, Behrens CF, Ceberg S. Surface guided radiotherapy (SGRT) improves breast cancer patient setup accuracy. J Appl Clin Med Phys. 2019;20:61–8.
Kang S, Jin H, Chang JH, Jang BS, Shin KH, Choi CH, Kim JI. Evaluation of initial patient setup methods for breast cancer between surface-guided radiation therapy and laser alignment based on skin marking in the Halcyon system. Radiat Oncol. 2023;18:60.
Mueller B, Song Y, Chia-Ko W, Hsu HY, Zhai X, Tamas P, Powell S, Cahlon O, McCormick B, Khan A, Gillespie E, Cervino L, Zhao B, Hong L, Braunstein LZ. Accuracy and efficiency of patient setup using surface imaging versus skin tattoos for accelerated partial breast irradiation. Adv Radiat Oncol. 2023;8: 101183.
Jin JY, Yin FF, Tenn SE, Medin PM, Solberg TD. Use of the BrainLAB ExacTrac X-Ray 6D system in image-guided radiotherapy. Med Dosim. 2008;33:124–34.
Ohtakara K, Hayashi S, Tanaka H, Hoshi H, Kitahara M, Matsuyama K, Okada H. Clinical comparison of positional accuracy and stability between dedicated versus conventional masks for immobilization in cranial stereotactic radiotherapy using 6-degree-of-freedom image guidance system-integrated platform. Radiother Oncol. 2012;102:198–205.
Guckenberger M, Meyer J, Vordermark D, Baier K, Wilbert J, Flentje M. Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study. Int J Radiat Oncol Biol Phys. 2006;65:934–42.
Radiotherapy Kataurokai. Working Group for standardization of skin marking. https://drive.google.com/file/d/1qpgpCqZJOcG8V2VBbClHOdx5V8lE2d6m/view (Oct 2021, date last accessed).
Ederer C, Sprenger A, Prokopetz M, Kofler LM, Wegmayr A, Lukas P. Hygienic aspects of marker pens in radiation therapy. Strahlenther Onkol. 2018;194:861–3.
Katano A, Nozawa Y, Imae T, Yamashita H, Nakagawa K. An invisible skin marker for external beam radiation therapy: utilization of ultraviolet fluorescent marker pens. Cureus. 2023;15: e34347.
Acknowledgements
We thank Ms. Hiromi Murakami, Mr. Masafumi Shigita, and Mr. Yoshito Kadowaki for their best support. We thank Ashleigh Cooper, PhD, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.
Funding
This work was supported partly by Japan Society for the Promotion of Science (JSPS) KAKENHI [Grant Number 23K07194].
Author information
Authors and Affiliations
Contributions
HM conceptualized the data. SN, HM, and MH designed the methodology. MH, SK, and SN involved in formal analysis and investigated the data. SN wrote and prepared the original draft. KN and HM wrote, reviewed, and edited the article. HM acquired the funding. YM supervised the data. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Hajime Monzen received a research donation from Hayakawa Rubber Co., Ltd.
Ethical approval
This study was approved by the Institutional Review Board of the Okayama Central Hospital on January 27, 2023.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Nakayama, S., Hirose, M., Kaneshige, S. et al. Development and evaluation of a novel water-based pigment marker for radiation therapy skin marking. Radiol Phys Technol 16, 543–551 (2023). https://doi.org/10.1007/s12194-023-00743-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12194-023-00743-0